UPCC 17422 Expedited CAR T-cell Manufacturing from r/r DLBCL Patient Specimens

Enrolling By Invitation
99 years or below
All
Phase N/A
25 participants needed
1 Location

Brief description of study

To investigate the efficacy and expansion of CAR T-cells manufactured in an expedited fashion in patient-derived xenograft models (mice).

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: Medical Research
  • Age: 99 years or below
  • Gender: All

TBD

Updated on 22 Apr 2026. Study ID: 22-0122
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu For Cancer trials contact Penn Medicine's Cancer Trial Navigator at: PMCancerResearch@pennmedicine.upenn.edu or 215-349-8245

Study is selecting its participants from a population, or group of people, decided on by the researchers in advance.

Contact Abramson Cancer Center Navigator